The results showed inconsistent expression of SERCA3 in different types of cancer; it had significantly low expression in 13 cancers, including GBM, GBMLGG, LGG, COAD, COADREAD, KIRP, KIPAN, PRAD, LUSC, THCA, READ, BLCA, and KICH. This evidence concerns the gene ATP2A3 and glioblastoma.